<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA: Polypharmacy Topic Collection</title>
    <link>http://jama.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Sun, 01 Jan 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:51:06 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@jama.jamanetwork.com</managingEditor>
    <webMaster>webmaster@jama.jamanetwork.com</webMaster>
    <item>
      <title>Studies Explore Factors That Underlie Varied Responses to Cancer Drugs</title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=182211</link>
      <pubDate>Wed, 09 Jul 2008 00:00:00 GMT</pubDate>
      <author>Hampton T. </author>
      <description>&lt;span class="paragraphSection"&gt;Chicago—New research findings in the field of personalized medicine could help oncologists understand the characteristics that determine why patients respond differently to therapeutic drugs. The studies were presented recently at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">300</prism:volume>
      <prism:number xmlns:prism="prism">2</prism:number>
      <prism:startingPage xmlns:prism="prism">155</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">156</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.300.2.155</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=182211</guid>
    </item>
  </channel>
</rss>